S.Biomedics’ Parkinson's Cell Therapy Shows Early Clinical Promise

Expectations Rise For High-Dose Data

Parkinson's disease
Phase I/IIa Low-Dose Cohort Data Promising For Parkinson's Cell Therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia